Discontinuation rate of sulfasalazine, leflunomide and methotrexate due to adverse events in a real-life setting (NOR-DMARD).

Pawel Mielnik,Joseph Sexton,Karen M Fagerli,Gunnstein Bakland, Yi Hu,Eirik K Kristianslund,Mari Hoff,Ada Wierød,Tore K Kvien

Rheumatology advances in practice（2023）

引用 0|浏览12

暂无评分

摘要

Our work has shown a similar AE profile of csDMARDs to previous data. However, higher discontinuation rates for SSZ and LEF cannot be explained easily from AE profiles.

查看译文

关键词

RA, MTX, LEF, SSZ, discontinuation, adverse events

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要